Literature DB >> 1851501

Absence of human papilloma virus in cervical adenocarcinoma determined by in situ hybridisation.

F I Young1, L M Ward, L J Brown.   

Abstract

A few studies using DNA technology have suggested that human papillomavirus (HPV) may be an aetiological factor for adenocarcinoma of the uterine cervix. Twenty one cases of cervical adenocarcinoma were studied by in situ hybridisation using biotinylated DNA probes for HPV types 6, 11, 16 and 18 and a streptavidin, biotinylated alkaline phosphatase detection system. Intranuclear HPV DNA was detected in none of the adenocarcinomas, while positive controls gave a clear intranuclear signal. Adjacent areas of normal, koilocytic, and dysplastic squamous epithelium also gave positive results. It may be that squamous epithelium contaminates adenocarcinomas reported as positive by Southern blotting. Our results showing absence of detectable HPV DNA within adenocarcinomas suggest that HPV infection may not have a major role in the aetiology of adenocarcinoma of the uterine cervix.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1851501      PMCID: PMC496915          DOI: 10.1136/jcp.44.4.340

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  6 in total

1.  Human papillomavirus types and localization in adenocarcinoma and adenosquamous carcinoma of the uterine cervix: a study by in situ DNA hybridization.

Authors:  T Tase; T Okagaki; B A Clark; D A Manias; R S Ostrow; L B Twiggs; A J Faras
Journal:  Cancer Res       Date:  1988-02-15       Impact factor: 12.701

2.  Human papillomavirus deoxyribonucleic acid in adenocarcinoma and adenosquamous carcinoma of the uterine cervix.

Authors:  D Smotkin; J S Berek; Y S Fu; N F Hacker; F J Major; F O Wettstein
Journal:  Obstet Gynecol       Date:  1986-08       Impact factor: 7.661

3.  Adenocarcinoma of the cervix associated with human papillomavirus.

Authors:  S P Wilczynski; J Walker; S Y Liao; S Bergen; M Berman
Journal:  Cancer       Date:  1988-10-01       Impact factor: 6.860

4.  Human papillomavirus DNA in adenocarcinoma in situ, microinvasive adenocarcinoma of the uterine cervix, and coexisting cervical squamous intraepithelial neoplasia.

Authors:  T Tase; T Okagaki; B A Clark; L B Twiggs; R S Ostrow; A J Faras
Journal:  Int J Gynecol Pathol       Date:  1989       Impact factor: 2.762

5.  Human papillomavirus messenger RNA expression in adenocarcinoma in situ of the uterine cervix.

Authors:  A Farnsworth; C Laverty; M H Stoler
Journal:  Int J Gynecol Pathol       Date:  1989       Impact factor: 2.762

6.  Glandular lesions of the uterine cervix: the present state of our knowledge.

Authors:  M Wells; L J Brown
Journal:  Histopathology       Date:  1986-08       Impact factor: 5.087

  6 in total
  6 in total

1.  Absence of human papillomavirus in cervical adenocarcinoma.

Authors:  R G Wright; M L Samaratunga; R Jaworski
Journal:  J Clin Pathol       Date:  1992-03       Impact factor: 3.411

2.  Human papillomavirus DNA in glandular lesions of the uterine cervix.

Authors:  H Samaratunga; N Cox; R G Wright
Journal:  J Clin Pathol       Date:  1993-08       Impact factor: 3.411

3.  Predominance of serum antibodies to synthetic peptide stemming from HPV 18 open reading frame E2 in cervical adenocarcinoma.

Authors:  M Lehtinen; A Leminen; J Paavonen; P Lehtovirta; H Hyöty; E Vesterinen; J Dillner
Journal:  J Clin Pathol       Date:  1992-06       Impact factor: 3.411

4.  Integration of human papillomavirus types 16 and 18 in cervical adenocarcinoma.

Authors:  K Cooper; C S Herrington; E S Lo; M F Evans; J O McGee
Journal:  J Clin Pathol       Date:  1992-05       Impact factor: 3.411

Review 5.  Molecular events in uterine cervical cancer.

Authors:  S A Southern; C S Herrington
Journal:  Sex Transm Infect       Date:  1998-04       Impact factor: 3.519

6.  Detection of high-risk human papillomavirus subtypes in cervical glandular neoplasia by in situ hybridization.

Authors:  Zhang Sheng; Hiroshi Minato; Toshiyuki Sasagawa; Satoko Nakada; Eriko Kinoshita; Nozomu Kurose; Takayuki Nojima; Satoru Makinoda
Journal:  Int J Clin Exp Pathol       Date:  2013-09-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.